Ticker | $ Bought |
---|---|
31,168,800 |
Vida Ventures Advisors, LLC has about 61.6% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 61.6 |
Others | 38.4 |
Vida Ventures Advisors, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
SMALL-CAP | 49 |
UNALLOCATED | 38.4 |
MID-CAP | 10.6 |
MICRO-CAP | 2 |
About 14.2% of the stocks held by Vida Ventures Advisors, LLC either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
Others | 85.8 |
RUSSELL 2000 | 14.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Vida Ventures Advisors, LLC has 6 stocks in it's portfolio. KRON proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for Vida Ventures Advisors, LLC last quarter.
Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ALLO | allogene therapeutics, inc. | 3.63 | 1,798,160 | 5,034,860 | unchanged | 0.00 | ||
CNTA | centessa pharmaceuticals plc | 45.36 | 3,931,820 | 62,869,800 | unchanged | 0.00 | ||
DYN | dyne therapeutics, inc. | 10.56 | 407,499 | 14,637,400 | unchanged | 0.00 | ||
KRON | kronos bio, inc. | 2.00 | 2,765,310 | 2,765,310 | unchanged | 0.00 | ||
tectonic therapeutics, inc. | 22.49 | 1,028,670 | 31,168,800 | new | ||||
kyverna therapeutics, inc. | 15.96 | 4,523,920 | 22,122,000 | unchanged | 0.00 | |||